Healthtech Startups

Empower Sleep offers virtual sleep care, connecting patients with sleep doctors for online provider visits, at-home sleep testing, and personalized treatment plans based on continuous sleep tracking data. It serves consumers seeking sleep health support and accepts qualifying insurance plans.

3 investors

EmpowerU is a tech-enabled mental health support solution for schools and colleges, combining online skill-building lessons with daily 1:1 coaching by trained mental health experts to help students build resilience and improve wellbeing, attendance, and grades. It offers site-based licenses to schools as well as a credit-bearing course delivered through third-party online schools or directly, serving students across the United States.

3 investors

ENB Therapeutics develops small molecules targeting the endothelin B receptor (ETBR) in the tumor microenvironment to treat drug-resistant cancers by restoring immune cell infiltration and promoting tertiary lymphoid organ formation. Its preclinical therapies target cancers including melanoma, glioblastoma, squamous cell carcinoma, bladder cancer, and ovarian cancer.

3 investors

Specialty pharmaceutical company managing prescription dermatology assets.

3 investors

Endo Tools Therapeutics develops endoscopic devices to enable minimally invasive therapeutic surgical procedures in gastroenterology. The company serves physicians and patients requiring complex gastrointestinal interventions.

3 investors

EndoRobotics builds robotic and manual platforms that convert a standard diagnostic endoscope into a precise surgical tool for endoluminal therapies such as ESD, EMR, and defect closure. Spun out of Korea University, the company serves gastroenterologists and surgeons performing complex, incisionless GI procedures.

3 investors

EndoShunt develops a catheter-based device to control hemorrhage in traumatic vascular injuries, featuring a length-adjustable occlusion zone, temporary deployment, and an atraumatic tip. The company has functional prototypes validated in benchtop and in vivo studies and is pursuing FDA 510(k) clearance.

3 investors

Endostart develops and manufactures medical devices for gastrointestinal endoscopy, aimed at healthcare sector professionals. Founded in 2018, the company operates in the medical device industry.

3 investors

Enlitic provides artificial intelligence solutions for healthcare systems to improve medical imaging data quality and unlock new revenue opportunities. The company's intelligent data framework enhances data quality, orchestrates workflows, and enables better comprehension of imaging archives.

3 investors

EnsiliTech develops ensilication technology, a silica-based method to stabilise vaccines and biopharmaceuticals so they can be stored and transported without refrigeration. The company serves the pharmaceutical and biotech industry and originated from research at the University of Bath.

3 investors

enstem develops industry-specific services for non-desk workers that use smartwatches and vital-sensing devices to monitor health and safety. Its offerings target the logistics/transportation industry and on-site field workers in Japan.

3 investors

Enterprise Therapeutics is a drug discovery company developing therapies for respiratory diseases such as cystic fibrosis, asthma, and COPD. Its research targets the underlying mechanisms of mucus congestion in the lungs to reduce lung infections and improve patient quality of life.

3 investors

Enthera Srl is a privately held pharmaceutical company founded in 2016 and based in Milan, Italy.

3 investors

Enumera Molecular develops technology and a platform for simplified, lower-cost workflows that enable liquid biopsy and high-dimensional omics assays for laboratories. It targets clinical labs performing molecular diagnostics.

3 investors

Enyo Pharma is a biotechnology company focused on drug development in the life sciences and therapeutics field. This page lists the venture capital and institutional firms that back the company.

3 investors

Enzo is an AI-native software platform built specifically for home health agencies, unifying intake, scheduling, documentation, OASIS, coding, QA, billing, quality management, and reporting on a single system. It automates routine work and flags cases needing human review, addressing home health workflows such as PDGM, RAP/NOA, and episode-based care.

3 investors

Enzyme develops a Quality Management System (QMS) software platform for life science companies including drug, biologic, device, and digital product manufacturers, designed to streamline regulatory workflows and generate FDA-ready documentation.

3 investors

Ephemeral produces semi-permanent tattoo ink formulated to fade naturally over 2 years, offering an alternative to permanent tattoos that do not require laser removal. The company sells ink directly and through a network of approved tattoo artist partners.

3 investors

Epicured is a meal delivery service offering low FODMAP and gluten-free prepared entrees, soups, salads, and smoothies that are dietitian-approved and aimed at people with digestive and gut-health issues. Its menu is developed by a culinary team in consultation with registered dietitians and clinicians.

3 investors

Epigenic Therapeutics develops gene regulation-based biotherapeutics using its EPIREG platform, which applies AI algorithms to design CRISPR-Cas components that regulate target gene expression without altering the DNA sequence. Combined with a lipid nanoparticle delivery system, the technology targets metabolic, cardiovascular, viral hepatitis, ocular, oncology and rare diseases.

3 investors

Epigno develops management systems for medical and nursing care institutions and provides related consulting services. The company serves healthcare and elderly-care organizations in Japan.

3 investors

Epimab Biotherapeutics is a clinical-stage biopharmaceutical company specializing in the development of bispecific antibodies using proprietary technology platforms including FIT-Ig® and MAT-Fab. The company is advancing a pipeline of novel candidates targeting unmet clinical needs, with a focus on oncology applications.

3 investors

Epiodyne develops small-molecule opioids designed to optimize therapeutic outcomes, with initial focus on safer pain relief and improved opioid use disorder treatment with reduced addiction and respiratory depression risk. The company uses a platform approach to tune drug candidates across a spectrum from inhibitors to full agonists.

3 investors

Epitopea develops off-the-shelf cancer vaccines targeting aberrantly expressed tumor-specific antigens using its proprietary CryptoMap platform. The company serves patients with difficult-to-treat cancers across oncology.

3 investors